Target intelligence / Profile preview

Meiotic nuclear division protein 1 homolog (MND1)

Target
MND1
Molecular classification
Other (meiosis-specific DNA-binding protein; not a receptor, enzyme, channel, or transporter), Forms a complex with Hop2; contains a winged-helix domain and coiled-coil leucine zipper regions
01

Overview

Meiotic nuclear division protein 1 homolog (MND1) is a highly conserved eukaryotic protein necessary for proper homologous chromosome pairing and the resolution of meiotic double-strand breaks. In mammals, the MND1 protein forms a stable heterodimeric complex with Hop2. This complex binds both DNA and recombinase proteins (Dmc1, Rad51), stimulating their activity to drive strand invasion and cross-over events during the meiotic recombination process. Structurally, MND1 contains a winged-helix DNA-binding domain and several coiled-coil leucine zipper regions that facilitate dimerization and protein interactions. Loss of MND1 function causes severe defects in meiosis, resulting in infertility conditions such as primary ovarian insufficiency and azoospermia. MND1 is not typically regarded as a druggable therapeutic target and has limited clinical biomarker value, but is crucial for germline genome integrity.

Other names
Meiotic nuclear divisions 1MND1GAJMeiotic nuclear division protein 1 homologHomolog of yeast MND1
02

Mechanism of action

Not applicable (no drugs are known to target MND1 directly)

03

Biological functions

Homologous chromosome pairingGrouping and repairing of double-strand DNA breaksFacilitates strand invasion/assimilation events during homologous recombination in meiosis
04

Disease associations

Primary ovarian insufficiencyAzoospermiaImpairment can result in meiotic failure and infertility
05

Safety considerations

None known (MND1 is essential for normal meiosis; gene knockout causes infertility but is not a therapeutic risk in clinical settings)
06

Interacting drugs

None known (no direct pharmacological modulators identified)
07

Biomarkers

None established for clinical patient selection or efficacy monitoring

Beyond the preview

Go deeper on Meiotic nuclear division protein 1 homolog (MND1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meiotic nuclear division protein 1 homolog (MND1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call